How cells start making proteins
Dynamics of Eukaryotic Ribosomal Scanning
This study is looking at how cells start making proteins, which is really important for helping them adapt to changes and stress, and it could help us understand how problems in this process might lead to diseases like cancer and developmental disorders.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-10892838 on NIH RePORTER |
What this research studies
This research investigates the process by which cells initiate protein synthesis, a critical function for responding to environmental changes and stress. It focuses on understanding how the ribosomal pre-initiation complex scans messenger RNA to find the correct starting point for translation. By examining the dynamics of this scanning mechanism, the research aims to uncover the fundamental properties that govern this process, which is essential for maintaining healthy cellular function. The findings could provide insights into how dysregulated translation contributes to diseases like cancer and developmental disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by conditions related to dysregulated protein synthesis, including certain cancers and developmental disorders.
Not a fit: Patients with conditions unrelated to protein synthesis or those not experiencing dysregulated translation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating diseases associated with protein synthesis errors, such as cancer and viral infections.
How similar studies have performed: While the scanning mechanism of ribosomal initiation has been proposed for decades, this research aims to experimentally validate its properties, making it a novel approach in this area.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: O'leary, Sean E — University of California Riverside
- Study coordinator: O'leary, Sean E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.